Analysts have raised their price target for American Healthcare REIT from $46.00 to $46.75, citing slight improvements in profit margin forecasts and a marginally higher fair value projection.
What's in the News
- American Healthcare REIT, Inc. has filed for a follow-on equity offering worth $1 billion, involving common stock in an at-the-market offering. (Key Developments)
- The company has completed a follow-on equity offering, issuing 3,554,525 common stock securities under an income trust structure. (Key Developments)
- Earnings guidance for 2025 has been raised, with expected net income per diluted share increasing to a range of $0.33 to $0.37 from previous guidance of $0.29 to $0.35. The same-store net operating income growth guidance has increased to a range of 11.0% to 14.0%. (Key Developments)
- American Healthcare REIT, Inc. continues to seek acquisitions, focusing on high-quality long-term care assets and building a pipeline of over $300 million in awarded deals. (Key Developments)
Valuation Changes
- Fair Value has risen slightly from $46.00 to $46.75.
- Discount Rate has increased marginally from 7.27% to 7.30%.
- Revenue Growth projections remain virtually unchanged at 7.78%.
- Net Profit Margin has improved modestly from 7.57% to 7.65%.
- Future P/E ratio has edged down from 58.17x to 57.98x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.